|
Anders Hedegaard joined Bavarian Nordic in August 2007. He comes from a position as member of ALK-Abelló’s Corporate Management in charge of Business Operations. His management career includes executive positions with Aga, Foss and Novo Nordisk.
He is Chairman of the Board of Bavarian Nordic Holding Inc., Bavarian Nordic Inc. and BN ImmunoTherapeutics Inc.
He holds a M.Sc. in Chemical Engineering from the Technical University of Denmark |